2015 Fiscal Year Final Research Report
Development of cancer peptide vaccine that can induce tumor-specific CTLs and Th cells.
| Project/Area Number |
26893206
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Surgical dentistry
|
|---|
| Research Institution | Kumamoto University |
|---|
Principal Investigator |
Yuno Akira 熊本大学, 医学部附属病院, 医員 (40738473)
|
|---|
| Project Period (FY) |
2014-08-29 – 2016-03-31
|
| Keywords | がんペプチドワクチン療法 / キラーT細胞 / ヘルパーT細胞 / 腫瘍免疫 |
|---|
| Outline of Final Research Achievements |
Recently, it is reported the efficacy of cancer immunotherapy including cancer peptide vaccine. Many reports show cancer peptide vaccine can induce CTL. There are not only CTL but also Th cells in the T cell subset and they roll important function for eradication of tumor. So we tried to identify the epitope can induce both CTL and Th cells and conduct immunological analysis.
|
| Free Research Field |
がんペプチドワクチン療法
|
